After reviewing hundreds of hours of surgical video, a team led by Cedars-Sinai investigators has created a system that links ...

A simple urine test was found to detect prostate cancer with greater accuracy than the standard PSA (prostate-specific ...

Thanks to a new Food and Drug Administration (FDA) approval, an innovative new treatment approach is now available to significantly more men with advanced prostate cancer. The administration expanded ...

Mohammad Mahmoud, MD, looks ahead to the 2025 American Urological Association (AUA) meeting in Las Vegas, which will feature a robust program on metastatic prostate cancer centering on new ...

Whether you're an athlete, a senior, a busy professional, or someone on your feet all day, Akusoli insoles are positioned among the best magnetic acupressure insoles for pain relief. Their ...

including prostate cancer or an enlarged prostate. Routine testing is not currently available on the NHS, but patients may be offered a PSA test if a GP suspects they have prostate cancer.

A new at-home spit test for prostate cancer may be better than current testing methods, a new study has suggested. Experts have developed a new saliva test which analyses genetic variants in a man ...

The new spit test can be completed at home without needing to visit a GP. Credit: PA A new spit test for detecting prostate cancer may be more effective than traditional blood tests at detecting ...

The results of the BARCODE1 trial, published by The New England Journal of Medicine assesses the use of a polygenic risk score in screening for prostate cancer. Prof Michael Inouye, Professor of ...

The development is a major boost to the Mail's campaign for a national prostate cancer screening programme, aimed at preventing needless deaths. Prostate cancer is the most diagnosed form of ...

This is the trouble with prostate cancer screening and is why, despite pressure from charities, the National Screening Committee (NSC) and scientists are reluctant to add it to the list of routine ...

The incidence of prostate cancer is increasing. Screening with an assay of prostate-specific antigen (PSA) has a high rate for false positive results. Genomewide association studies have ...